Mostra i principali dati dell'item

dc.contributor.authorRobles Valero, Javier 
dc.contributor.authorFernández-Nevado, Lucía
dc.contributor.authorCuadrado López, Myriam
dc.contributor.authorLorenzo Martín, Luis Francisco 
dc.contributor.authorFernández-Pisonero, Isabel
dc.contributor.authorAbad, Antonio
dc.contributor.authorRedín, Esther
dc.contributor.authorMontuenga, Luis
dc.contributor.authorMartín-Zanca, Dionisio
dc.contributor.authorBigas, Anna
dc.contributor.authorMallo, Moisés
dc.contributor.authorDosil Castro, Mercedes 
dc.contributor.authorBustelo, Xosé R. 
dc.date.accessioned2026-01-09T12:54:34Z
dc.date.available2026-01-09T12:54:34Z
dc.date.issued2022-08-30
dc.identifier.citationRobles-Valero, J., Fernández-Nevado, L., Cuadrado, M., Lorenzo-Martín, L., Fernández-Pisonero, I., Abad, A., ... & Bustelo, X. R. (2022). Characterization of the spectrum of trivalent VAV1 mutation-driven tumors using a gene-edited mouse model [Dataset].es_ES
dc.identifier.issn1574-7891
dc.identifier.urihttp://hdl.handle.net/10366/168603
dc.description.abstract[EN]Mutations in the VAV1 guanine nucleotide exchange factor 1 have been recently found in peripheral T cell lymphoma and nonsmall-cell lung cancer (NSCLC). To understand their pathogenic potential, we generated a gene-edited mouse model that expresses a VAV1 mutant protein that recapitulates the signalling alterations present in the VAV1 mutant subclass most frequently found in tumours. We could not detect any overt tumourigenic process in those mice. However, the concurrent elimination of the Trp53 tumour suppressor gene in them drives T cell lymphomagenesis. This process represents an exacerbation of the normal functions that wild-type VAV1 plays in follicular helper T cells. We also found that, in combination with the Kras oncogene, the VAV1 mutant version favours progression of NSCLC. These data indicate that VAV1 mutations play critical, although highly cell-type-specific, roles in tumourigenesis. They also indicate that such functions are contingent on the mutational landscape of the tumours involved.es_ES
dc.language.isoenges_ES
dc.publisherFEBS and Wileyes_ES
dc.rightsAttribution-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nd/4.0/*
dc.subjectRAC1es_ES
dc.subjectTP53es_ES
dc.subjectAngioimmunoblastic T cell lymphomaes_ES
dc.subjectFollicular helper T cellses_ES
dc.subjectNonsmall-cell lung canceres_ES
dc.subjectPeripheral T cell lymphomaes_ES
dc.subject.meshProto-Oncogene Proteins p21(ras) *
dc.subject.meshMutant Proteins *
dc.subject.meshMutation *
dc.subject.meshAnimals *
dc.subject.meshProto-Oncogene Proteins c-vav *
dc.subject.meshNeoplasms *
dc.subject.meshMice *
dc.titleCharacterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse modeles_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://10.1002/1878-0261.13295es_ES
dc.subject.unesco3207.13 Oncologíaes_ES
dc.identifier.doi10.1002/1878-0261.13295
dc.relation.projectIDRTI2018‐096481‐B‐100 grant cofounded by MCIN/AEI/10.13039/501100011033 and the European Research Development Fund “A way of making Europe”, the Spanish Association against Cancer (GC16173472GARC), the Castilla‐León autonomous government (CSI252P18, CSI145P20, CLC‐2017‐01), and “la Caixa” Banking Foundation (HR20‐00164). Funding also from the Carlos III Health Institute (PI20/01724). LFes_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.pmid35895495
dc.identifier.essn1878-0261
dc.journal.titleMolecular Oncologyes_ES
dc.volume.number16es_ES
dc.issue.number19es_ES
dc.page.initial3533es_ES
dc.page.final3553es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsneoplasias *
dc.subject.decsanimales *
dc.subject.decsproteínas protooncogénicas c-vav *
dc.subject.decsratones *
dc.subject.decsmutación *
dc.subject.decsproteínas mutantes *
dc.subject.decsproteínas protooncogénicas p21(ras) *


Files in questo item

Thumbnail

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item

Attribution-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NoDerivatives 4.0 Internacional